Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host disease. - Raguraman V; Mysinger M; Verma M; Mohiyuddin S; Jabbour N; Kesler M; Joshi T; Palaniyandi S; Hildebrandt GC (Frontiers in immunology, 2026)